Botulinum toxin for cricopharyngeal dysfunction in Parkinson's disease.
Restivo
Domenico A
DA
Palmeri
Agostino
A
Marchese-Ragona
Rosario
R
D000368:Aged; D019274:Botulinum Toxins, Type A / Q000627:therapeutic use*; D003680:Deglutition Disorders / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000627:therapeutic use*; D010300:Parkinson Disease / Q000150:complications* / Q000188:drug therapy
D009465:Neuromuscular Agents; D019274:Botulinum Toxins, Type A